🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

225 results for “Shanghai” Clear

  1. Qing'E pill

    Shanghai University of Traditional Chinese Medicine

    Menopause

    phase 1 small molecule completed

    1 trial

  2. Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo

    Shanghai University of Traditional Chinese Medicine

    Healthy

    phase 1 small molecule completed

    1 trial

  3. Recombinant erythropoietin stimulating protein

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Renal Failure

    phase 1 small molecule active

    1 trial

  4. Recombinant human thrombopoietin

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Liver Cirrhosis

    phase 1 small molecule active

    1 trial

  5. Recombinant oncolytic herpes simplex virus type Ⅰ (R130)

    Shanghai University of Traditional Chinese Medicine

    Osteosarcoma

    phase 1 small molecule active

    1 trial

  6. Rongliflozin

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  7. SCT-001 CAR-T cells

    Shanghai University of Traditional Chinese Medicine

    Ovarian Cancer

    phase 1 mab active

    1 trial

  8. SPGL008

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  9. SSGJ-612

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  10. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Arthritis, Gouty

    phase 1 small molecule active

    1 trial

  11. SSGJ-613

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule active

    1 trial

  12. SSGJ-705

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Receptor, ErbB-2

    phase 1 small molecule active

    1 trial

  13. SSGJ-706

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors Patients

    phase 1 small molecule active

    1 trial

  14. SSGJ-709

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Malignant Tumors

    phase 1 small molecule active

    1 trial

  15. SSS11

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Gout

    phase 1 mab active

    1 trial

  16. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Anemia in Chronic Kidney Diseases

    phase 1 small molecule active

    2 trials

  17. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects (HS)

    phase 1 small molecule completed

    1 trial

  18. SSS39

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety and Tolerability in Healthy Volunteers

    phase 1 small molecule active

    1 trial

  19. SSS55

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety Issues

    phase 1 small molecule active

    1 trial

  20. SSS59

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Malignant Tumors

    phase 1 small molecule active

    1 trial

  21. SSS67 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule active

    1 trial

  22. SYHA1813 oral solution (2.0g:25mg)

    Shanghai University of Traditional Chinese Medicine

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  23. TQB2825 Injection (Subcutaneous Injection)

    Shanghai University of Traditional Chinese Medicine

    CD20-positive Hematological Malignancies

    phase 1 small molecule active

    1 trial

  24. YZJ-1139 tablets

    Shanghai University of Traditional Chinese Medicine

    Insomnia

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources